Asmanex HFA (mometasone furoate) NDC 78206-113

NDC codes

FDA NDC Directory

Product NDC (as listed)78206-113Labeler and product segments. Claims need a package NDC.

Product NDC at billing width78206-0113Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
78206-113-01	78206011301	1 CANISTER in 1 CARTON (78206-113-01) / 120 AEROSOL in 1 CANISTERMarketed from Jun 1, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Asmanex HFA
Generic name (nonproprietary): mometasone furoate
Active ingredients: Mometasone furoate — 200 ug/1
Dosage form: Aerosol
Route: Respiratory (Inhalation)
Labeler: Organon LLC
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 205641
Marketing start: Jun 1, 2021
Listing expires: Dec 31, 2027
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 78206-113_9236ed5b-6c38-451e-ab80-284ac04d5d67SPL ID 9236ed5b-6c38-451e-ab80-284ac04d5d67SPL set ID 0c6d63da-41bc-4894-bead-198e66c848acRxCUI 1536142, 1536144, 1536147, 1536148, 2196790, 2196792UNII 04201GDN4R
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N478206011301 followed by a unit qualifier and the quantity

Package 78206-0113-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 7, 2026.

Indications (excerpt from the label)

ASMANEX HFA is a corticosteroid indicated for: Maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. ( 1.1 ) Important limitations: Not indicated for the relief of acute bronchospasm. ( 1.1 ) 1.1 Treatment of Asthma ASMANEX ® HFA is indicated for the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Important Limitations of Use ASMANEX HFA is NOT indicated for the relief of acute bronchospasm.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 205641

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 205641
Product	Strength	Form · route	Labeler	Product NDC
Asmanex HFAmometasone furoate	Mometasone furoate 50 ug/1	AerosolRespiratory (Inhalation)	Organon LLC	78206-111
Asmanex HFAmometasone furoate	Mometasone furoate 100 ug/1	AerosolRespiratory (Inhalation)	Organon LLC	78206-112